What does "Research Use Only" (RUO) mean?
RUO stands for Research Use Only. It means the product is intended exclusively for laboratory and scientific research - as a reagent or research material. It is not a medicine, not a dietary supplement, not a cosmetic, and it is not approved for use in humans or animals. This label is not marketing fine print; it defines the product's legal intended purpose. The moment a product crosses that line - for example, if it is sold with dosing instructions or claims about treating a condition - it becomes a medicine in the eyes of the law, and the trade in medicines is governed by entirely different, far stricter rules.
Who can buy peptides - only companies, or individuals too?
A common misconception is that research peptides can only be purchased by companies, universities, or registered laboratories. In practice, buying a research reagent usually carries no requirement to be a registered institution - an individual can buy them too. What matters is understanding what you are buying: you are buying research material, not a medicine. Purchasing a product that is lawfully sold as a research reagent does not put an individual outside the law. So the real question is less "who is allowed to buy" and more "what exactly am I buying" - and the answer is: a research compound with a clearly defined intended purpose.
The legal "gray zone"
This is where it gets more sensitive. In the European Union, research peptides are not approved medicines. That means no legitimate supplier may sell them for human use, advise on dosing or method of use, or make health claims. In this, every serious supplier is in exactly the same position: we sell strictly for research purposes. The ones actually crossing the legal line are vendors who promise "dosing instructions", advise on injecting, or market these products as treatments. Responsibility for any use outside laboratory research rests entirely with the individual. This is precisely why Peptid.si does not and cannot provide instructions for human use - that is not dodging the question, it is following the law.
What stage is the research at?
To complete the picture: some peptides are in active pharmaceutical development. Retatrutide, for example, is being studied by Eli Lilly in large clinical trials in the US for obesity and type 2 diabetes, with very promising results. Yet even a peptide like that is (still) not an approved medicine in Europe - until it passes all phases of clinical trials and receives authorization from the EMA or national authorities, it remains a research compound. Most other peptides are at an even earlier stage, supported mainly by preclinical (animal) data. In other words: "being researched" is not the same as "approved for use".
How and why people buy anyway
The market reality is that demand is driven by social media and personal stories, not by regulatory processes. People buy peptides from all kinds of suppliers - often via social media, with no certificate of analysis, sometimes mislabeled or impure. They do so on their own responsibility and at their own risk. This is exactly where suppliers differ. If someone does decide to enter this space, the two most important questions are: does the supplier publish an independent certificate of analysis (COA) for every batch, and is purity confirmed by HPLC and mass spectrometry? Without that data, you genuinely do not know what is in the vial.
What the Slovenian regulator (JAZMP) says
In April 2026, the Agency for Medicinal Products and Medical Devices of the Republic of Slovenia (JAZMP) published a warning on the use of peptides for injection. It explains that peptides in injectable form are classified as medicines and may only be used if they hold a marketing authorization. It points to websites offering injectable peptides without such authorization, and to risks such as unknown composition, possible contamination, and serious adverse effects, and it advises consumers against buying such products. We take this warning seriously and we agree with it. It is for exactly these reasons that Peptid.si supplies peptides strictly for research purposes and not for injection or human use, publishes an independent certificate of analysis (COA) for every batch, which directly addresses the risk of unknown composition and contamination, and provides no instructions for dosing, preparation, or method of use. The JAZMP warning concerns products offered or used as unauthorized medicines for human injection, which is not the same as supplying research compounds for laboratory purposes.
What Peptid.si can and cannot do
Let us be completely clear. Peptid.si supplies research peptides with laboratory-verified purity and publicly available certificates of analysis in the COA Vault. We are proud of that, and it is our main advantage. At the same time, we cannot and may not: advise on dosing, method of use, or injection; give medical advice; or sell products for human use. For health questions, consult a qualified medical professional. This article is educational and does not constitute legal or medical advice; laws vary between countries and change over time, so check the rules that apply to your specific situation.
References / Links
- European Parliament and Council of the EU (2001). Directive 2001/83/EC on the Community code relating to medicinal products for human use. EUR-Lex. Web
- European Medicines Agency (EMA) (2024). Obtaining an EU marketing authorisation for a medicine. EMA. Web
- Agency for Medicinal Products and Medical Devices of the Republic of Slovenia (JAZMP) (2026). Warning on the use of peptides for injection (Opozorilo glede uporabe peptidov za injiciranje). JAZMP. Web
- Jastreboff AM, Kaplan LM, Frías JP, Wu Q, et al. (2023). Triple–Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial. N Engl J Med. PubMed
